recommend reiter market perform recommend
follow rb releas inde despit improv seen rb
origin busi exclud ifcn believ market might still adopt
cautiou stanc new temporari issu affect busi
manufactur issu ifcn believ sens deja-vu
problem korea cyber-attack unsuccess product
launch scholl estim fair valu stand close current share price
highlight confer call
new issu rb organ sale growth infantil child nutrit
ifcn declin surprisingli sale affect
manufactur disrupt european plant due technic
engin issu weigh sale
issu resolv shipment back normal manag
believ could sell-out drag octob earli novemb
could lead sell-in impact partli off-set stock
underli perform hygien satisfactori
thu outperform categori growth achiev thank
success launch implement rb price also
improv rb believ continu would
in-lin comment made unilev manag
rest also stronger notabl driven over-the-counter
although scholl sale continu declin modest pace
group confid abil reach upper-end
full-year organ sale growth guidanc impli acceler
round rje look achiev given
sound trend hyho rest health expect replenish
ifcn expect consensu stood
trim ep averag expect
sale report basi cer guidanc
l-f-l slightli lower margin forecast
vs expect rb fulli recov loss
attribut ifcn manufactur issu weigh cost
absorpt although could partli off-set better-than-expect
trend divis
publish rjee rjfi
rb creat merger two
compani reckitt colman benckis
major player person hpc
sector group post sale
present wide rang categori thank
larg portfolio focus powerbrand
two busi consum sale
hygien product group
expand consum health divis reach
infantil nutrit follow complet
acquisit mead johnson nutrit compani mjn
june
 price previou day close unless
footnot ep adjust except item
valuat dcf base fair valu come see impli ev/cop broadli in-lin hpc
sector believ justifi group close market growth rje
pleas read domest foreign disclosure/risk inform begin page analyst certif page
raymond jame euro equiti rjee authoris regul autorit de contrl prudentiel et de rsolut autorit de march financi cib
raymond jame intern limit rjfi authoris regul uk conduct author frn collect refer raymond
ifcn weigh
rb under-perform peer due ifcn
rb organ sale growth hyho improv satisfactorili
overview estim
overview organ sale growth forecast divis
rest health
rb gradual catch market perform
overview chang forecast
chg bp
discount cash flow
number share million
profit tax except
chang wcr
roe tax
roce tax
number share dilut
